Friday, March 19, 2010

Avandia Researchers' Financial Ties Questioned

FRIDAY, March 19 (HealthDay News) -- A new review of studies on the controversial diabetes drug Avandia finds that most of the researchers who reported positive results had financial ties to pharmaceutical companies, but it's not clear if being paid by drug makers directly leads to supportive research.
The review authors found that 94 percent of the researchers who penned positive studies about the drug Avandia (rosiglitazone) had been paid by pharmaceutical companies. The drug, which treats type 2 diabetes, has been linked to heart attacks. Read more.

Avandia is a well-known Type 2 diabetes drug made by GlaxoSmithKline. According to government reports, many people who are taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month. I find articles like this every week!